Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)

NCT00109564 is registered in ClinicalTrials.gov with Targacept Inc. as lead sponsor.

NCT NCT00109564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00109564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Safety and Efficacy Study of TC-1734-112 in Subjects With Age Associated Memory Impairment (AAMI)
Lead sponsor
Targacept Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
October 31, 2005
Enrollment
174
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

age-related memory disorders